Sabra Health Care REIT Stock Price, News & Analysis (NASDAQ:SBRA)

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last twelve months. There are currently 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings or view top-rated stocks.

11 Wall Street analysts have issued 1-year price objectives for Sabra Health Care REIT's stock. Their SBRA share price targets range from $12.50 to $16.00. On average, they anticipate the company's share price to reach $14.59 in the next twelve months. This suggests a possible upside of 0.9% from the stock's current price.
View analysts price targets for SBRA or view top-rated stocks among Wall Street analysts.

Sabra Health Care REIT's stock was trading at $12.43 on January 1st, 2023. Since then, SBRA shares have increased by 16.3% and is now trading at $14.46.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our SBRA earnings forecast.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) released its quarterly earnings data on Wednesday, May, 4th. The real estate investment trust reported $0.18 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative net margin of 13.61% and a negative trailing twelve-month return on equity of 2.98%. During the same quarter last year, the company earned $0.39 EPS.

Sabra Health Care REIT declared a quarterly dividend on Monday, November 6th. Stockholders of record on Friday, November 17th will be paid a dividend of $0.30 per share on Thursday, November 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.30%. The ex-dividend date is Thursday, November 16th.
Read our dividend analysis for SBRA.

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.28%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

ETFs with the largest weight of Sabra Health Care REIT (NASDAQ:SBRA) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), Principal Real Estate Active Opportunities ETF (BYRE), ALPS REIT Dividend Dogs ETF (RDOG), JPMorgan Realty Income ETF (JPRE), Cambria Global Real Estate ETF (BLDG), Hoya Capital High Dividend Yield ETF (RIET), Global X SuperDividend ETF (SDIV) and iShares Residential and Multisector Real Estate ETF (REZ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Sabra Health Care REIT's stock is owned by a variety of institutional and retail investors. Top institutional investors include Principal Financial Group Inc. (9.08%), JPMorgan Chase & Co. (5.84%), Bank of New York Mellon Corp (2.13%), LSV Asset Management (1.85%), Charles Schwab Investment Management Inc. (1.77%) and Northern Trust Corp (1.45%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews, Michael J Foster and Michael Lourenco Costa.
View institutional ownership trends.

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.